Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis

By sjmartinez • April 5, 2023

Kugelmas M, Loftus M, Owen EJ, Wadei H, Saab S. Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis. Am J Health Syst Pharm. 2023 Apr 4:zxad070. doi: 10.1093/ajhp/zxad070. Epub ahead of print. PMID: 37013893.

Tags: albumin, ascites, Cirrhosis, Digestive Diseases, hepatorenal syndrome, Publications, spontaneous bacterial peritonitis, terlipressin

Increasing Goals of Care Discussions Among Veterans with Cirrhosis: A Veterans Health Administration Quality Improvement Initiative

Patel AA, O'Leary JG, Bajaj JS, Prause N, Hannum R, Noll A, Cheung R, Giustini AB, Jakab SS, Nobbe A, Patton H, Perumalswami P, Spoutz[...]

Mechanisms and therapeutic insights into MASH-associated fibrosis

Zhu Y, Cai B. Mechanisms and therapeutic insights into MASH-associated fibrosis. Trends Endocrinol Metab. 2025 Sep 26:S1043-2760(25)00196-1. doi: 10.1016/j.tem.2025.09.004. Epub ahead of print. PMID: 41015698.

Functional alterations across motor, visual, and attention cerebellar and cortical networks in patients with asymptomatic spinal cord compression

Kostiuk A, Jafari M, Wang C, Mayer E, Salamon N, Holly LT, Ellingson BM. Functional alterations across motor, visual, and attention cerebellar and cortical networks[...]